What are the practical implications for providers of the FSA statements on structured investment products?
The FSA review titled Quality of Advice on Structured Investment Products, published last month, has already been the subject of considerable debate and blog activity in the adviser community. However, those firms marketing structured investment products are also affected by the FSA’s findings, in particular the guidance contained in papers covering the financial promotion of structured investment products and TCF implications. Some commentators have suggested it will take time for providers to absorb the detail of the review and anticipate product launches will be delayed or even cancelled...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
